RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Oceanpine Capital
O

Oceanpine Capital portfolio

Oceanpine Capital has 1 portfolio company on record at Recent Funding.

Website: oceanpine.net.
Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 1.
Capital in their rounds: $73M.
Latest deal: Immune-Onc Therapeutics · Mar 30, 2021.
About this page

It is a venture capital firm based in Beijing, CN, founded in 2016. Its most recent investment on record is Immune-Onc Therapeutics's $73M Series B+ round in March 2021, which it led, alongside Yanchuang Capital, Tao Capital, Octagon Capital Advisors and 6 others. That company is in Health and bio.

About Oceanpine Capital

Firm type: Venture capital.
Headquarters: Beijing, CN.
Founded: 2016.
Stages: Seed, Series A, Series B, Series C, Late Stage.
Sectors: Biotech, Consumer, Data & Infrastructure, EdTech, Enterprise Software, Hardware, Media & Entertainment, SaaS, Semiconductors.

What Oceanpine Capital invests in

How Oceanpine Capital invests

StageDealsCapital in rounds
Series B+ 1 100%$73M

Oceanpine Capital portfolio companies

CompanyRound with Oceanpine CapitalTotal raisedLatest raise
IImmune-Onc Therapeutics
Health and bio
Series B+ · $73M · lead$211MJan 5, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Oceanpine Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Oceanpine Capital, which is a subset of its real portfolio. API: /api/v1/investors/oceanpine-capital (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy